Jatenzo is a Oral Capsule, Liquid Filled in the Human Prescription Drug category. It is labeled and distributed by Clarus Therapeutics, Inc.. The primary component is Testosterone Undecanoate.
Product ID | 69087-198_92470a45-8a11-69a6-e053-2a95a90a9e32 |
NDC | 69087-198 |
Product Type | Human Prescription Drug |
Proprietary Name | Jatenzo |
Generic Name | Testosterone Undecanoate |
Dosage Form | Capsule, Liquid Filled |
Route of Administration | ORAL |
Marketing Start Date | 2019-08-01 |
Marketing Category | NDA / NDA |
Application Number | NDA206089 |
Labeler Name | Clarus Therapeutics, Inc. |
Substance Name | TESTOSTERONE UNDECANOATE |
Active Ingredient Strength | 198 mg/1 |
Pharm Classes | Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [CS] |
DEA Schedule | CIII |
NDC Exclude Flag | N |
Listing Certified Through | 2020-12-31 |
Marketing Start Date | 2019-08-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA206089 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2019-08-01 |
Ingredient | Strength |
---|---|
TESTOSTERONE UNDECANOATE | 198 mg/1 |
SPL SET ID: | ed7b5d41-7475-4c10-99b9-b62b3434ae60 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
69087-158 | Jatenzo | testosterone undecanoate |
69087-198 | Jatenzo | testosterone undecanoate |
69087-237 | Jatenzo | testosterone undecanoate |
67979-511 | Aveed | testosterone undecanoate |
80603-101 | Kyzatrex | TESTOSTERONE UNDECANOATE |
80603-103 | Kyzatrex | TESTOSTERONE UNDECANOATE |
80603-105 | Kyzatrex | TESTOSTERONE UNDECANOATE |
54436-112 | Tlando | testosterone undecanoate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
JATENZO 88379456 not registered Live/Pending |
Clarus Therapeutics, Inc. 2019-04-10 |
JATENZO 86756177 5019220 Live/Registered |
Clarus Therapeutics, Inc. 2015-09-14 |